Invasive fungal rhinosinusitis (IFRS) represents a severe, life‐threatening infection of the nasal cavity and paranasal sinuses that almost exclusively affects individuals with compromised immune ...

Most people are familiar with bacterial sinus infections that come with seasonal colds or allergies, but another, potentially more serious type of infection often goes unrecognized until it causes ...

accurate diagnosis depends on histologic examination and culturing [5]. Although special stains have been recommended, such as periodic acid-Schiff, Gridley versus fungus, and methenamine silver ...

A fungal ball is a mass that develops in your sinuses after you’ve breathed in fungal spores. Medications cannot treat it, but a doctor can surgically remove it. Sinus fungal balls are a type of ...

Please provide your email address to receive an email when new articles are posted on . Patients treated with isavuconazole as primary or salvage therapy for invasive fungal sinusitis experienced ...

Positive results from the pivotal LIBERTY-AFRS-AIMS phase 3 study (NCT04684524) evaluating the investigational use of Dupixent (dupilumab) in adults and children aged 6 years and older with allergic ...

Several years ago, researchers at Mayo Clinic made startling claims that chronic rhinosinusitis -- a baffling inflammation of the sinuses -- was caused not by bacterial infections but by fungi. The ...

AFRS, a subtype of chronic rhinosinusitis, is a chronic type 2 inflammatory disease of the sinuses caused by an intense allergic hypersensitivity to fungi, most usually aspergillus. It primarily ...

We reviewed 110 charts from patients who had had chronic sinusitis. Five (4.5%) of those patients had fungal sinusitis, 52 (47%) had allergic sinusitis, and 53 (48%) had infectious sinusitis.

ACAAI: Sanofi and Regeneron's Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...